Clinical Research

depression.jpg

Psychiatry, neuroradiology researchers find imaging markers of inheritable depression

Children are at heightened risk of major clinical depression when at least one parent has a history of the disorder. New research shows depression markers appearing on structural and functional brain MRI ahead of symptoms in these “familial risk” offspring from infancy through early adulthood.

October 18, 2022
brain.jpg

Brain imaging scans unlock mysteries about depression and resilience

The new findings may contain important implications for neuromodulation therapies to treat depression symptoms.

October 17, 2022
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella heart pumps linked to improved high-risk PCI outcomes

Researchers examined data from patients who underwent high-risk PCI with either an Impella heart pump or an intra-aortic balloon pump.

October 13, 2022
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 

Metformin, the popular type 2 diabetes medication, may be an effective AFib treatment

A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 

October 12, 2022

Experts blame 'perverse incentives' for scientific fraud in radiology research

Nearly 30% of corresponding authors included in the analysis shared that they had witnessed scientific fraud in their department within the last five years.

October 10, 2022
Anthony Fauci receiving his first dose of the Moderna COVID-19 vaccine in December 2020. Photo by Nihchiachi Chang

Cardiologist says COVID-19 vaccinations ‘must stop’ due to the risk of adverse events—scientists and doctors push back

A well-known cardiologist who once fully supported COVID-19 vaccines is now saying he thinks they have done more harm than good. Online, as one might expect, people on both sides of this particular debate have been quick to respond. 

October 7, 2022
Wake Forest University School of Medicine has received a five-year grant worth $30 million from the National Institute of Aging, part of the National Institutes of Health, to study the potential benefits of a new-look rehabilitation program on patients who are hospitalized with heart failure with preserved ejection fraction (HFpEF).

Can strength and endurance training help heart failure patients live longer?

Researchers have received a five-year grant worth $30 million to study how a new-look physical rehab program impacts outcomes among older HFpEF patients.

October 6, 2022
The FDA has cleared tirzepatide (Mounjaro) from Eli Lilly, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1) for improving glycemic control among adults with type 2 diabetes.

FDA grants fast track designation to tirzepatide, Eli Lilly’s new type 2 diabetes drug, for treating obesity

Back in May, tirzepatide was approved by the FDA for improving glycemic control among adults with type 2 diabetes.

October 6, 2022